Abstract
Transcatheter aortic valve implantation (TAVI) represents a therapeutic option of increasing impact for the treatment of high-risk patients with symptomatic, severe aortic valve stenosis. We report here the case of an 86-year old patient with a cutaneo-pericardial fistula after a transapical TAVI procedure.
MeSH terms
-
Aged, 80 and over
-
Anti-Bacterial Agents / therapeutic use
-
Aortic Valve Stenosis / therapy*
-
Cardiac Catheterization / adverse effects*
-
Cardiac Surgical Procedures
-
Cutaneous Fistula / diagnostic imaging
-
Cutaneous Fistula / etiology*
-
Cutaneous Fistula / microbiology
-
Cutaneous Fistula / therapy
-
Female
-
Heart Diseases / diagnostic imaging
-
Heart Diseases / etiology*
-
Heart Diseases / microbiology
-
Heart Diseases / therapy
-
Heart Valve Prosthesis Implantation / adverse effects*
-
Heart Valve Prosthesis Implantation / methods
-
Humans
-
Pericardium* / diagnostic imaging
-
Pericardium* / microbiology
-
Pericardium* / surgery
-
Proteus Infections / etiology
-
Proteus Infections / microbiology
-
Proteus Infections / therapy
-
Proteus mirabilis / isolation & purification
-
Tomography, X-Ray Computed
-
Treatment Outcome
-
Wound Infection / etiology*
-
Wound Infection / microbiology
-
Wound Infection / therapy